MEOX2 and central nervous system cancer: Immunoblotting and RT-PCR analysis results showed that mRNA and protein levels of MEOX2 in fresh glioma tissues were significantly higher than it’s in NBT, especially in Grade3, 4 gliomas (Fig. 1F and Fig. S1D).